Dr. Emily Horowitz - Rave Reviews For MDMA’s Therapeutic Potential
Rave New World 🌎✨
What's the deal with Psychedelics?!
They have the power to facilitate a mystical-level experience, but for the last two decades, they’ve been regarded as a threat.
Yet, with the recent permission to study these substances, they’re proving to be some of the best healing alternatives for PTSD.
How is that possible?!
In today's episode, we sit down with Dr. Emily Horowitz, PYSD, a clinical psychologist, to talk about her current work with MAPS for the clinical trials of MDMA.
What is MDMA?
MDMA is a synthetic compound with structural similarities to both the classic hallucinogen mescaline and psychostimulants or amphetamines. Unlike some other psychedelics, this one was created in a lab.
It was discovered just before the First World War but wasn't studied until the '50s and '60s.
It was studied because the U.S. military wanted to use the substance for military purposes like: interrogation, intelligence, and counterintelligence.
By the 1980s, the U.S. Drug Enforcement Administration (DEA) prohibited the use of MDMA altogether.
However, over the past decade, there has been a resurgence in research to evaluate MDMA's therapeutic benefits, particularly for post-traumatic stress disorder (PTSD).
The organization MAPS is at the forefront of this revolution.
Curious about how a once-popular then prohibited drug gets evaluated?
Check out this week's podcast to find out!
To learn more about Dr. Horowitz go here: https://resonantmindcollective.com/2020/10/05/emily-horowitz-maps-interview/
What's the deal with Psychedelics?!
They have the power to facilitate a mystical-level experience, but for the last two decades, they’ve been regarded as a threat.
Yet, with the recent permission to study these substances, they’re proving to be some of the best healing alternatives for PTSD.
How is that possible?!
In today's episode, we sit down with Dr. Emily Horowitz, PYSD, a clinical psychologist, to talk about her current work with MAPS for the clinical trials of MDMA.
What is MDMA?
MDMA is a synthetic compound with structural similarities to both the classic hallucinogen mescaline and psychostimulants or amphetamines. Unlike some other psychedelics, this one was created in a lab.
It was discovered just before the First World War but wasn't studied until the '50s and '60s.
It was studied because the U.S. military wanted to use the substance for military purposes like: interrogation, intelligence, and counterintelligence.
By the 1980s, the U.S. Drug Enforcement Administration (DEA) prohibited the use of MDMA altogether.
However, over the past decade, there has been a resurgence in research to evaluate MDMA's therapeutic benefits, particularly for post-traumatic stress disorder (PTSD).
The organization MAPS is at the forefront of this revolution.
Curious about how a once-popular then prohibited drug gets evaluated?
Check out this week's podcast to find out!
To learn more about Dr. Horowitz go here: https://resonantmindcollective.com/2020/10/05/emily-horowitz-maps-interview/
Activity